Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002997:Clomipramine / Q000494:pharmacology; D003863:Depression / Q000188:drug therapy; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid / Q000378:metabolism; D008094:Lithium / Q000494:pharmacology / Q000627:therapeutic use; D008954:Models, Biological; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D010672:Phenytoin / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000096:biosynthesis / Q000378:metabolism*; D013569:Synapses / Q000187:drug effects / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D014364:Tryptophan / Q000378:metabolism / Q000627:therapeutic use
D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D013973:Thyrotropin-Releasing Hormone; D010672:Phenytoin; D014364:Tryptophan; D008094:Lithium; D002997:Clomipramine; D004298:Dopamine